Equities

Hims & Hers Health Inc

Hims & Hers Health Inc

Actions
  • Price (EUR)21.36
  • Today's Change-0.61 / -2.78%
  • Shares traded300.00
  • 1 Year change+228.62%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 18:32 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Hims & Hers Health Inc grew revenues 65.49% from 526.92m to 872.00m while net income improved from a loss of 65.68m to a smaller loss of 23.55m.
Gross margin81.13%
Net profit margin8.15%
Operating margin3.45%
Return on assets19.93%
Return on equity26.35%
Return on investment25.93%
More ▼

Cash flow in USDView more

In 2023, Hims & Hers Health Inc increased its cash reserves by 104.75%, or 49.89m. The company earned 73.48m from its operations for a Cash Flow Margin of 8.43%. In addition the company used 12.11m on investing activities and also paid 11.48m in financing cash flows.
Cash flow per share0.5048
Price/Cash flow per share44.49
Book value per share2.02
Tangible book value per share1.30
More ▼

Balance sheet in USDView more

Hims & Hers Health Inc uses little or no debt in its capital structure.
Current ratio2.14
Quick ratio1.82
Total debt/total equity0.00
Total debt/total capital0.00
More ▼

Growth rates in USD

SmartText is unavailable
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
351.71
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.